A detailed history of Aldebaran Capital, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Aldebaran Capital, LLC holds 1,043,152 shares of ACRS stock, worth $2.55 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares
1,043,152
Previous 858,152 21.56%
Holding current value
$2.55 Million
Previous $944 Million 27.08%
% of portfolio
1.1%
Previous 0.88%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1.12 - $1.4 $207,200 - $258,999
185,000 Added 21.56%
1,043,152 $1.2 Billion
Q2 2024

Aug 13, 2024

BUY
$1.01 - $1.36 $866,733 - $1.17 Million
858,152 New
858,152 $944 Million

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $163M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Aldebaran Capital, LLC Portfolio

Follow Aldebaran Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aldebaran Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aldebaran Capital, LLC with notifications on news.